MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 74 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,608,522 | +7.0% | 240,776 | -12.4% | 0.00% | +100.0% |
| Q2 2023 | $7,111,560 | -24.5% | 274,896 | -29.9% | 0.00% | -50.0% |
| Q1 2023 | $9,424,776 | +9.4% | 392,372 | -11.2% | 0.00% | 0.0% |
| Q4 2022 | $8,614,613 | +73.7% | 441,775 | +87.2% | 0.00% | +100.0% |
| Q3 2022 | $4,959,000 | +109.2% | 236,028 | +93.8% | 0.00% | 0.0% |
| Q2 2022 | $2,370,000 | +274.4% | 121,808 | +323.9% | 0.00% | – |
| Q1 2022 | $633,000 | -3.8% | 28,737 | -30.4% | 0.00% | – |
| Q4 2021 | $658,000 | +48.9% | 41,273 | +80.1% | 0.00% | – |
| Q3 2020 | $442,000 | -26.6% | 22,919 | -25.9% | 0.00% | – |
| Q2 2020 | $602,000 | +12.7% | 30,940 | -18.8% | 0.00% | – |
| Q1 2020 | $534,000 | +381.1% | 38,117 | +244.5% | 0.00% | – |
| Q3 2019 | $111,000 | – | 11,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |